Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OMEGA THERAPEUTICS, INC.

(OMGA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
9.45(c) 9.68(c) 9.25(c) 9.56(c) 9.97 Last
55 046 56 923 98 616 60 340 40 086 Volume
-1.15% +2.43% -4.44% +3.35% +4.29% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -71,6 M - -
Net cash position 2021 209 M - -
P/E ratio 2021 -3,56x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -156 M - -
Net cash position 2022 79,5 M - -
P/E ratio 2022 -2,57x
Yield 2022 -
Capitalization 457 M 457 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees -
Free-Float -
More Financials
Company
Omega Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused in a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to fundamentally transform human medicine in the service of patients. It is developing OMEGA Epigenomic Programming platform is designed to coopt nature's universal operating system by harnessing the power of epigenetics, the mechanism for gene control... 
More about the company
All news about OMEGA THERAPEUTICS, INC.
01/10Omega Therapeutics Announces Appointment of Yan Moore, M.D., as Chief Medical Officer
PR
01/10Omega Therapeutics Announces Appointment of Yan Moore as Chief Medical Officer
CI
2021OMEGA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direc..
AQ
2021Omega Therapeutics, Inc. and Pacific Western Bank Enters into the Fourth Amendment to t..
CI
2021OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to S&P Global BMI Index
CI
2021OMEGA THERAPEUTICS, INC.(NASDAQGS : OMGA) added to NASDAQ Biotechnology Index
CI
2021Omega Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare C..
PR
2021Omega Therapeutics Narrows Loss in Q3
MT
2021Omega Therapeutics Reports Third Quarter 2021 Financial Results and Outlines Key Corpor..
PU
2021OMEGA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
AQ
2021Omega Therapeutics Reports Third Quarter 2021 Financial Results and Outlines Key Corpor..
PR
2021Omega Therapeutics to Present at the Jefferies London Healthcare Conference
PR
2021OMEGA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direc..
AQ
2021OMEGA THERAPEUTICS : Working With Stanford University to Explore Use of Omega Epigenomic C..
MT
2021OMEGA THERAPEUTICS : Announces Strategic Research Collaboration with Stanford University S..
PR
More news
News in other languages on OMEGA THERAPEUTICS, INC.
01/10Omega Therapeutics annonce la nomination de Yan Moore au poste de directeur médical.
2021Omega Therapeutics réduit sa perte au troisième trimestre
2021La perte d'Omega Therapeutics au deuxième trimestre se creuse en raison de l'augmentati..
2021Omega Therapeutics chute lors de son entrée au Nasdaq après avoir fixé le prix de son i..
More news
Analyst Recommendations on OMEGA THERAPEUTICS, INC.
More recommendations
Chart OMEGA THERAPEUTICS, INC.
Duration : Period :
Omega Therapeutics, Inc. Technical Analysis Chart | OMGA | US68217N1054 | MarketScreener
Technical analysis trends OMEGA THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 9,56 $
Average target price 29,50 $
Spread / Average Target 209%
EPS Revisions
Managers and Directors
Mahesh Karande President, Chief Executive Officer & Director
Roger A. Sawhney Chief Financial Officer
Noubar B. Afeyan Chairman
Thomas McCauley Chief Scientific Officer
Yan Moore Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
OMEGA THERAPEUTICS, INC.-15.62%457
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842